| Updated in 9/22/2022 6:22:41 PM |
Viewed: 83 times |
(Journal Article) |
Oncogene 37 (4): 461-477 (2018)
EZH2 promotes neoplastic transformation through VAV interaction-dependent extranuclear mechanisms.
N Venkatesan
,
J F Wong
,
K P Tan
,
H H Chung
,
Y H Yau
,
E Cukuroglu
,
A Allahverdi
,
L Nordenskiöld
,
J Göke
,
S Geifman-Shochat
,
V C L Lin
,
M S Madhusudhan
,
I-H Su
ABSTRACT
Recently, we reported that the histone methyltransferase, EZH2, controls leukocyte migration through interaction with the cytoskeleton remodeling effector, VAV, and direct methylation of the cytoskeletal regulatory protein, Talin. However, it is unclear whether this extranuclear, epigenetic-independent function of EZH2 has a profound impact on the initiation of cellular transformation and metastasis. Here, we show that EZH2 increases Talin1 methylation and cleavage, thereby enhancing adhesion turnover and promoting accelerated tumorigenesis. This transforming capacity is abolished by targeted disruption of EZH2 interaction with VAV. Furthermore, our studies demonstrate that EZH2 in the cytoplasm is closely associated with cancer stem cell properties, and that overexpression of EZH2, a mutant EZH2 lacking its nuclear localization signal (EZH2ΔNLS), or a methyl-mimicking Talin1 mutant substantially promotes JAK2-dependent STAT3 activation and cellular transformation. Taken together, our results suggest a critical role for the VAV interaction-dependent, extranuclear action of EZH2 in neoplastic transformation.